Beta ‐amyloid PET imaging for Alzheimer's dementia diagnosis

Alzheimer's dementia is the most commonly diagnosed dementia. Despite this, diagnosis can be especially complex in certain circumstances. Any additional, novel diagnostic aids can positively add to the diagnostic process, overall accuracy and ultimately to patient care and treatment. Beta ‐amyloid (Aβ) positron emission tomography (PET) imaging is utilised as an important diagnostic tool in NHS dementia research in the UK and worldwide. Aβ PET imaging is now licensed for clinical use in the UK. This review explores the potential for the use of Aβ PET imaging in clinical practice highlighting recent evidence base followed by a discussion of potential benefits in the context of important clinical and practical considerations.
Source: Progress in Neurology and Psychiatry - Category: Neurology Authors: Tags: Review Source Type: research